Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides. - Anderson BA; Freestone GC; Low A; De-Hoyos CL; Iii WJD; Østergaard ME; Migawa MT; Fazio M; Wan WB; Berdeja A; Scandalis E; Burel SA; et al. (Nucleic acids research, 2021)